Detalhe da pesquisa
1.
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Oncologist
; 26(8): e1418-e1426, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586299
2.
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA.
Lancet Oncol
; 18(1): 22-23, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049571
3.
Japanese regulatory authority's perspective on biosimilars - authors' reply.
Lancet Oncol
; 16(3): e102, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25752553
4.
A Case Report with Severe Thrombocytopenia Induced by Axitinib.
Case Rep Hematol
; 2020: 7520783, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32089908
5.
Interactions of cytokine gene polymorphisms in prostate cancer risk.
Carcinogenesis
; 29(3): 573-8, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18174250
6.
Reply: To PMID 25283701.
Urology
; 84(6): 1262, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25283704